A Study of CS1001 in Subjects with Advanced Solid Tumors
NCT03744403
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
CS1001
Sponsor
CStone Pharmaceuticals